CLINICAL TRIAL

Treatment for Spinal Cord Injuries

Recruiting · 18+ · All Sexes · Chicago, IL

Effect of a Novel Intervention Using Daily Intermittent Hypoxia and High Intensity Training on Upper Limb Function in Individuals With Spinal Cord Injury

See full description

About the trial for Spinal Cord Injuries

Eligible Conditions
Wounds and Injuries · Spinal Cord Injuries · Hypoxia

Treatment Groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase < 1 and are in the first stage of evaluation with people.

Control Group 1
Upper extremity training/Armeo Spring
COMBINATIONPRODUCT
Control Group 2
Upper extremity training/Armeo Spring
COMBINATIONPRODUCT

Eligibility

This trial is for patients born any sex aged 18 and older. There are 9 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Be able to demonstrate some hand muscle activation, or use of a tenodesis grasp (wrist extension)
At least 6 months post injury
History of a non-progressive spinal cord injury, inclusive of levels of C1-T1.
Etiology of spinal cord injury is non-progressive in nature
Participants do NOT have to stop taking antispasticity medications to participate in the study.
Must be asymptomatic (no dizziness, lightheadedness, etc)
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 4 weeks
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 4 weeks.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 1 primary outcome and 2 secondary outcomes in patients with Spinal Cord Injuries. Measurement will happen over the course of 4 weeks.

GRASSP
4 WEEKS
Graded Redefined Assessment of Strength, Sensation and Prehension
grip strength
4 WEEKS
hand strength
9-hole peg test
4 WEEKS
coordination

Who is running the study

Principal Investigator
Z. R.
Zev Rymer, Investigator
Shirley Ryan AbilityLab

Patient Q & A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

There is not cost involved in participating in this trial, so insurance won't be necessary.

See if you qualify for this trial
Get access to this novel treatment for Spinal Cord Injuries by sharing your contact details with the study coordinator.